Member Info for Mars1

CD4 is produced in Cambridge that is above the 2m per week does not impact Alva

From placing money original target in April for LFTs was 2m per week with kit bought by ODX. Some kit now being provided by DHS, so was that always the case or is this more kit? So does that mean more than 2m tests a week?

Nothing has changed, make loads sell all, plan on track

All the out-facing connections internal and external, have changed. No titbits just official news, what are the new lawyers up to?

7 weeks left in qtr 1, all part of the coming weeks.

https://www.gov.uk/guidance/lateral-flow-validation-prioritisation-criteria-for-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens

8 weeks until April, profit capacity undefined but substantially higher than the current NAV. Based on production of LTFs it can be £20m a month, but the end to end Elisa test/ laboratory testing service has potential to understate that number due to the higher cost/margin service. Cambridge has capacity to produce 46,000 Elisa tests a day although the lab will be more limited. Still surprised at the doldrums of the SP given Govt want more than U.K. companies can provide.

First 3 are ticks in the tweet.

Gregg 31st Jan
Omega Diagnostics
@OmegaDiagnostic
·
Jan 31
To-do list:

? Launch Mologic ELISA antibody test service
? Massively scale up Alva production facility
? Ensure Mologic Tech Transfer is on track
? Finish ramping up capacity to 2 million tests a week
? Buy office blinds .....
Ticks are done
Best Mars

Not ramping up from 500k a week as already now at 900k as that was the roadmap and ODX are on schedule.

Re previous ODX tweets production capacity goes up to 900,000 tests a week in February

Laboratory services required £75-£100m, hard to understand why the price is where it is. Diversified services.
https://bidstats.uk/tenders/2020/W52/741343655

If you look at the Shredz link in the contract award the document on the right in the Deloitte docs refers to Omega. Equipment to produce Mologic tests?

If they use your lab also likely to use your Elisa test

Lilliport is less than one hour from Stansted Airport

Been invested since May19 so heading for a 2 yr anniversary, 2yrs in the life of a typical pharma company involved with novel drug development is nothing. 10yrs development and failure at phase 3 is a regular occurrence. So what is NFX attraction there is a growing bank of assets that can get to market in a very short timescale and a contract can drop any time. Looks like we will live with covid related issues for a long time to come one being lung related problems is it NFXs time to shine.

CK has said they are expanding both sites but we have heard very little regarding the Lilliport expansion

So Govt want 2m LTfs a day. CKs last target was 2.5m a week and that is worth over £200m profit a year. Can CK double his target with HMG machinery.

Vincennes Product plc is a law firm presumably used to file the US patent
https://lawyers.findlaw.com/lawyer/firm/products-liability-law/vincennes/indiana

From RNS 9/19 says the cannabinoid developed suitable across all range of products
“ This first resulting patent filing relates to novel forms of a naturally-occurring cannabinoid, which is the subject of growing scientific interest as its therapeutic promise becomes increasingly validated. The patented cannabinoid forms have immediate applications in both pharmaceutical and consumer products worldwide, ”
They will not be raising $53m to just develop the next patent. They will outsource manufacturing and have had time to line up interested parties.